CB Rank (Investor) 262,210

David Pritchard, Chief Executive Officer, is a seasoned biopharmaceutical executive with extensive experience leading innovative companies. He has previously served as CEO of several university-based and early stage startups and has worldwide experience in M&A, fund raising, licensing and alliance management, product development and business

development.

Number of Current Jobs 1
David Pritchard is the CEO at Cytex Therapeutics.
There is no recent news or activity for this profile.